# Transnasal Versus Suprazygomatic SPG Block in Persistant Idiopathic Facial Pain

> **NCT06496841** · — · COMPLETED · sponsor: **Diskapi Teaching and Research Hospital** · enrollment: 40 (actual)

## Conditions studied

- Headache
- Persistent Idiopathic Facial Pain

## Interventions

- **DRUG:** Transnasal Sphenopalatine ganglion block
- **DRUG:** Ultrasound-guided suprazygomatic sphenopalatine ganglion block

## Key facts

- **NCT ID:** NCT06496841
- **Lead sponsor:** Diskapi Teaching and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06496841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06496841, "Transnasal Versus Suprazygomatic SPG Block in Persistant Idiopathic Facial Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06496841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*